Stage-modified international prognostic index effectively predicts clinical outcome of localized primary gastric diffuse large B-cell lymphoma

Annals of Oncology

Volumn 10, Issue 12, 1999, Pages 1433-1440

  Cortelazzo, S ^g   Rossi, A ^h   Roggero, E ^a   Oldani, E ^h   Zucca, E ^a   Tondini, C ^b   Ambrosetti, A ^h   Pasini, F ^h   Pinotti, G ^c   Bertini, M ^d   Vitolo, U ^d   Busetto, M ^e   Gianni, L ^f   Cavalli, F ^a   Barbui, T ^h  

^a OSPEDALE SAN GIOVANNI   (Switzerland)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c OSPEDALE DI CIRCOLO   (Italy)

^d MOLINETTE HOSPITAL   (Italy)

^e Ospedale Umberto I   (Italy)

^f Ospedale 'Infermi'   (Italy)

^g OSPEDALI RIUNITI   (Italy)

^h NONE

Author keywords

Combined modality treatment; DLCL; PGL; Stage modified IPI

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; PREDNISONE; VINCRISTINE SULFATE;

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; STOMACH LYMPHOMA; TREATMENT OUTCOME;

EID: 16744365400     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008351427601     Document Type: Article

References (34)

1. Zucca E, Roggero E. Bertoni F and Cavalli F. Primary extranodal non-Hodgkin's lymphomas. Part I: Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 1997; 8: 727-37.
2. Roggero E, Zucca E, Pinotti G et al. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 1995; 122: 767-9.
3. Bayerdorffer E, Neubauer A, Rudolph B et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobarter pylori infection. Lancet 1995; 345: 1591-4.
4. Montalban C, Castrillo JM, Abraira V et al. Gastric B-cell mucosa-associated lymphoid tissue (MALT): Clinicopathological study and evaluation of the prognostic factors in 143 patients. Ann Oncol 1995; 6: 355-62.
5. Hammel P, Haioun C, Chaumette MT et al. Efficacy of single-agent chemotherapy in low-grade B-cell mucosa lymphoid tissue lymphoma with prominent gastric expression. J Clin Oncol 1995; 13: 2524-9.
6. Schlechter NR, Portlock CS, Yahalom J. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol 1998; 16: 1916-21.
7. Rossi A, Rohatiner AZS, Lister TA. Primary gastrointestinal non-Hodgkin's lymphoma: Still an unresolved question? Ann Oncol 1993; 4: 802-3 (Editorial).
8. Coiffier B, Salles G. Does surgery belong to medical history for gastric lymphomas? Ann Oncol 1997; 8: 419-21 (Editorial).
9. Shipp MA, Harrington DP et al. International non-Hodgkin's lymphoma prognostic factors project: A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987-94.
10. Miller TP, Dahlherg S, Cassady JR et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate and high-grade non-Hodgkin's lymphoma. N Engl J Med 1998; 339: 21-6.
11. Lewin Kj, Ranchod M, Dorfman RF. Lymphomas of the gastrointestinal tract: A study of 117 cases presenting with gastrointestinal disease. Cancer 1978; 42: 693-707.
12. Hermann R, Panahon AM, Barcos MP et al. Gastrointestinal involvement in non-Hodgkin's lymphoma. Cancer 1980; 46: 215-22.
13. Blackledge G, Bush H, Dodge OG et al. A study of gastrointestinal lymphoma. Clin Oncol 1979; 5: 209-19.
14. Rohatiner AZS on behalf of D'Amore F, Coiffier B, Crowther D et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994; 5: 397-400.
15. Cogliatti SB, Schmid U, Schumacher U et al. Primary B-cell gastric lymphoma: A Clinicopathological study of 145 patients. Gastroentcrology 1991; 101: 1159-70.
16. Radaszkiewicz T, Dragosics B, Bauer P. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: Factors relevant to prognosis. Gastroenterology 1992; 102: 1628-38.
17. Dragosics B, Bauer P, Radaszkiewicz T. Primary gastrointestinal non-Hodgkin's lymphomas. A retrospective clinicopathologic study of 150 cases. Cancer 1985; 55: 1060-73.
18. Taal BG, Boot H, van Heerde P et al. Primary non-Hodgkin lymphoma of the stomach: endoscopie pattern and prognosis in low- versus high-grade malignancy in relation to the MALT concept. Gut 1996; 39: 556-61.
19. Tondini C, Giardini R, Bozzetti F et al. Combined modality treatment for primary gastrointestinal non-Hodgkin's lymphoma: The Milan Cancer Institute Experience. Ann Oncol 1993; 4: 831-7.
20. Maor MH, Velasquez WS, Fuller LM, Silvermintz KB. Stomach conservation in stage IE and IIE gastric non-Hodgkin's lymphoma. J Clin Oncol 1990; 8: 266-71.
21. Taal B, Burgers JMV, van Heerde P et al. The clinical spectrum and treatment of primary non-Hodgkin's lymphoma of the stomach. Ann Oncol 1993; 4: 839-46.
22. Haim N, Leviov M, Ben-Arieh Y et at. Intermediate and high-grade gastric non-Hodgkin's lymphoma: A prospective study of non-surgical treatment with primary chemotherapy, with or without radiotherapy. Leuk Lymph 1995; 17: 321-6.
23. Aviles A, Diaz-Maqueo JC, de la Torre A et al. Is surgery necessary in the treatment of primary gastric non-Hodgkin lymphoma? Leuk Lymph 1991; 5: 365-9.
24. Koch P, Grothaus-Pinke B, Hiddeman W et al. Primary lymphoma of the stomach: Three-year results of a prospective multicenter study. Ann Oncol 1997; 8: S85-8.
25. Salles G, Herbrecht R, Tilly H et al. Aggressive primary gastrointestinal lymphomas: Review of 91 patients treated with the LNH-84 regimen. A study of the Groupe d'Etude des Lymphomes Agressifs. Am J Med 1991; 90: 77-84.
26. Tondini C, Balzarotti M, Santoro A, Bonadonna G. Controversies in the management of gastrointestinal lymphoma. Forum 1993; 3.5: 471-81.
27. Sheridan WP, Medley G, Brodie GN. Non-Hodgkin's lymphoma of the stomach: A prospective pilot study of surgery plus chemotherapy in early and advanced disease. J Clin Oncol 1985; 3: 495-500.
28. Shiu MH, Nisce LZ, Pinna A et al. Recent results of multimodal therapy of gastric lymphoma. Cancer 1986; 58: 1389-99.
29. Azab MB, Henry-Amar M, Rougier P et al. Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma. A multivariate analysis, report of 106 cases, and review of the literature. Cancer 1989; 64: 1208-17.
30. Roukos DH, Hottenrott C, Encke A et al. Primary gastric lymphomas: A clinicopathologic study with literature review. Surg Oncol 1994; 3: 115-25.
31. Shimm DS, Dosoretz DE, Anderson T et al. Primary gastric lymphoma. Cancer 1983; 52: 2044-8.
32. Tondini C, Balzarotti M, Santoro A et al. Initial chemotherapy for primary resectable large-cell lymphoma of the stomach. Ann Oncol 1997; 8: 497-9.
33. Kocher M, Muller R-P, Ross D et al. Radiotherapy for treatment of localized gastrointestinal non-Hodgkin's lymphoma. Radiat Oncol 1997; 42: 37-41.
34. Glick JK, Kim K, Earle J et al. An ECOG randomized phase III trial of CHOP vs. CHOP + radiotherapy for intermediate-grade early stage non-Hodgkin's lymphoma. Proc Am Soc Clin Oncol 1995; 14: 391 (Abstr 1221).